Scope and Criteria for Publication
Annals of Urologic Oncology (AUO, Ann Urol Oncol, p-ISSN: 2617-7765, e-ISSN: 2617-7773) is a peer-reviewed, international scientific journal committed to disseminating high-caliber research in the field of urologic oncology. The journal publishes original research addressing the molecular, cellular and clinical aspects of urologic tumors. The journal’s scope encompasses studies on risk assessment, cellular and molecular characterization, prevention, detection, diagnosis, and treatment strategies aimed at improving patient outcomes in urologic oncology. The journal primarily focusses on three subjects: bladder, prostate and kidney cancer. Additionally, studies on adrenal tumors, testicular cancer, and carcinoma of the penis are also welcomed.
AUO fully adheres to the COPE code of conduct and best practices for journal editors, ensuring accountability for everything published. Likewise, our readers are always informed about research funding, and the relationships between authors, reviewers and editorial board members are maintained in line with COPE recommendations.
Ownership
Peng Zhang (Asian Medical Press Ltd)
Contact: Peng Zhang
Tel: +86-18164057850
Email: monkeyzhangpeng@hotmail.com
Published By
The journal is published by Asian Medical Press Ltd.
Publishing Schedule
The inaugural issue of AUO (Volume 1, Issue 1) was released in November 2018. Until 2023, the journal was published semiyearly, after which it adopted a quarterly publication schedule.
Turnaround Times for Manuscripts after Submission
-
First editorial decision - 7 days
-
Peer review - 2 weeks
-
Revision time - 1-4 weeks
-
Ahead of print - within 1 month of being accepted
-
Formal publication - within 1-12 month of being accepted
Open Access
AUO is a platinum open access journal. All articles are immediately available online upon publication. This model permits any medium to use and distribute the content for non-commercial aims, provided that proper credit is given to both the authors and the journal.
Article Types
AUO publishes a diverse range of article types, including original articles, reviews, clinical trials, systematic reviews, mini reviews, case reports, letters to the editors, and perspectives/opinions.
Information for Contributors
The journal only considers manuscripts that present original work. Manuscripts that have been accepted for publication or already published elsewhere will not be considered. Detailed submission requirements, including our conflicts of interest disclosure and ethics policies are available in our Publication Ethics and Malpractice Statement.
Submission Process
Submissions to
AUO are processed through our proprietary Manuscript System, which facilitates online submission and peer review process. Registration and access are available at
http://em.asmepress.com/.
All Manuscripts must present previously unpublished data or novel interpretations, and should not be under consideration elsewhere. Manuscripts should be clear and well-organized, featuring concise headings and a balanced integration of text, figures and tables.
Disclosures
Each author must disclose any financial relationships relevant to the subject of the manuscript, including equity ownership, profit-sharing agreements, royalties, patents, and grants. While authors are not required to report specific amounts, they must indicate “none” if no such relationships exist.
Submit Manuscript